Intranasal recombinant protein subunit vaccine targeting TLR3 induces respiratory tract IgA and CD8 T cell responses and protects against respiratory virus infection
Katharina Wørzner(Statens Serum Institut), Gabriel Kristian Pedersen(Statens Serum Institut)
Cited by 11
Related Papers
Vaccine Adjuvants Differentially Affect Kinetics of Antibody and Germinal Center Responses
|Frontiers in Immunology|2020|64